High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus

被引:0
|
作者
T B Niewold
J Hua
T J A Lehman
J B Harley
M K Crow
机构
[1] Mary Kirkland Center for Lupus Research,
[2] Hospital for Special Surgery,undefined
[3] Oklahoma Medical Research Foundation,undefined
来源
Genes & Immunity | 2007年 / 8卷
关键词
interferon ; systemic lupus erythematosus; genetics; epidemiology; autoantibodies;
D O I
暂无
中图分类号
学科分类号
摘要
Interferon α (IFN-α) levels are elevated in many patients with systemic lupus erythematosus (SLE); however it is not known whether high serum IFN-α activity is a cause or a result of the disease. We studied 266 SLE patients and 405 of their healthy relatives, and frequently found high serum IFN-α activity in both patients and healthy relatives as compared to healthy unrelated individuals. High IFN-α activity was clustered in specific families in both SLE patients and their healthy first-degree relatives, suggesting a heritable trait. Heritability was also supported by quantitative familial correlation of IFN-α activity, concordance in affected sib pairs and frequent transmission of the high IFN-α activity trait from parents to offspring. Autoantibodies to RNA-binding proteins and double-stranded DNA were associated with high IFN-α activity in SLE patients; however these autoantibodies were very uncommon in healthy family members and did not explain the observed familial correlations. The frequency of high IFN-α activity was similar across all studied ethnic backgrounds. These data suggest that high serum IFN-α activity is a complex heritable trait, which plays a primary role in SLE pathogenesis.
引用
收藏
页码:492 / 502
页数:10
相关论文
共 50 条
  • [31] Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus
    Serikova, S. Yu.
    Kozlovskaya, N. L.
    Shilov, E. M.
    TERAPEVTICHESKII ARKHIV, 2008, 80 (06) : 52 - 58
  • [32] Interferon-gamma (IFN-γ) intronic variant (rs2430561) is a risk factor for systemic lupus erythematosus: Observation from a meta-analysis
    Sarangi, Surjyapratap
    Nahak, Suraj K.
    Padhi, Sunali
    Pradhan, Bidyutprabha
    Nayak, Nisha
    Pati, Abhijit
    Panda, Aditya K.
    LUPUS, 2023, 32 (02) : 284 - 294
  • [33] Disease activity as a major risk factor for osteonecrosis (ON) in early systemic lupus erythematosus (SLE).
    Fialho, Sonia C. M. S.
    Bonfa, Eloisa
    Vitule, Luis
    D'Amico, Elbio
    Caparbo, Valeria F.
    Gualandro, Sandra
    Pereira, Rosa M. R.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S433 - S433
  • [34] Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus
    Choe, Jung-Yoon
    Kim, Seong-Kyu
    INFLAMMATION RESEARCH, 2016, 65 (06) : 479 - 488
  • [35] Serum ferritin as a serologic marker of activity in systemic lupus erythematosus
    M.-K. Lim
    C.-K. Lee
    Y.S. Ju
    Y.S. Cho
    M.-S. Lee
    B. Yoo
    H.-B. Moon
    Rheumatology International, 2001, 20 : 89 - 93
  • [36] Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus
    Jung-Yoon Choe
    Seong-Kyu Kim
    Inflammation Research, 2016, 65 : 479 - 488
  • [37] Serum Calprotectin in Systemic Lupus Erythematosus: Is It a Good Activity Biomarker?
    Fabregas, Jordi Camins
    Martinez-Morillo, Melania
    Gifre, Laia
    Holgado, Susana
    Mateo, Lourdes
    Aparicio, Maria
    Riveros, Anne
    Casafont-Sole, Ivette
    Garcia, Yaiza
    Prior, Agueda
    Teniente-Serra, Aina
    Martinez-Caceres, Eva
    Olive-Marques, Alejandro
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [38] SERUM CALPROTECTIN IN SYSTEMIC LUPUS ERYTHEMATOSUS: IS IT A GOOD ACTIVITY BIOMARKER?
    Camins-Fabregas, Jordi
    Martinez-Morillo, Melania
    Teniente-Serra, Aina
    Nack, Annika
    Casafont-Sole, Ivette
    Gifre, Laia
    Aparicio-Espinar, Maria
    Riveros, Anne
    Prior-Espanol, Agueda
    Brandy-Garcia, Anahy
    Sanguesa-Gomez, Clara
    Holgado, Susana
    Mateo, Lourdes
    Martinez-Caceres, Eva
    Olive, Alejandro
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1711 - 1712
  • [39] SERUM TWEAK AS A BIOMARKER FOR DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS
    Kim, S-K.
    Choe, J-Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 813 - 813
  • [40] Serum ferritin as a serologic marker of activity in systemic lupus erythematosus
    Lim, MK
    Lee, CK
    Ju, YS
    Cho, YS
    Lee, RS
    Yoo, B
    Moon, HB
    RHEUMATOLOGY INTERNATIONAL, 2001, 20 (03) : 89 - 93